(Q33336836)

25 July 2017

1 reference

title

Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia (English)

1 reference

heparin-induced thrombocytopenia

25 July 2017

1 reference

1 reference

1 reference

L M Kondo

1

1 reference

25 July 2017

A K Wittkowsky

series ordinal

2

1 reference

25 July 2017

B S Wiggins

series ordinal

3

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

Annals of Pharmacotherapy

25 July 2017

published in

1 reference

25 July 2017

volume

35

1 reference

25 July 2017

issue

4

1 reference

25 July 2017

page(s)

440-451

1 reference

Development of argatroban, a direct thrombin inhibitor, and its clinical application

25 July 2017

cites work

1 reference

Newer strategies for the treatment of heparin-induced thrombocytopenia

21 January 2018

1 reference

Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects

21 January 2018

1 reference

Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor

21 January 2018

1 reference

Clinical Application of the Synthetic Thrombin Inhibitor, Argatroban (MD-805)

21 January 2018

1 reference

Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome

21 January 2018

1 reference

Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome

21 January 2018

1 reference

The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case report

21 January 2018

1 reference

Treatment of heparin-induced thrombocytopenia by use of argatroban, a synthetic thrombin inhibitor

21 January 2018

1 reference

Reactivation of unstable angina after the discontinuation of heparin

21 January 2018

1 reference

Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia

21 January 2018

1 reference

Hirudins: antithrombin anticoagulants

21 January 2018

1 reference

Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.

21 January 2018

1 reference

Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.10301

1 reference

25 July 2017

1 reference